Schizophrenia Etiology and Pathophysiology

Genetic and Environmental Factors

Schizophrenia is caused by a complex interaction between strong genetic factors (approximately 80% heritability) and environmental triggers, with no single gene or environmental factor being solely responsible 1, 2
Genetics represent the most important etiological component of schizophrenia, accounting for approximately 80% of the disease liability 1, 2
Multiple genes with small individual effects contribute to risk rather than a single causative gene 1, 2
Increased family history of schizophrenia and schizophrenia spectrum disorders is consistently found in patients with the condition 3

Pregnancy and birth complications, including intrauterine fetal hypoxia, are key environmental contributors to schizophrenia 1, 2
Childhood trauma is a significant environmental risk factor for schizophrenia 1, 2
Migration status, social isolation, and urbanicity are also associated with an increased risk of schizophrenia 1, 2
Substance abuse, particularly cannabis use, is a significant environmental risk factor for schizophrenia 1, 2

The disorder ultimately converges on disturbances in specific neurotransmitter systems, regardless of the diverse initial triggers, with dopamine and glutamate systems being most consistently implicated 1, 2
Neurobiological abnormalities include deficits in smooth-pursuit eye movements, autonomic responsivity, and progressive increases in ventricular size 3, 4
Progressive decrease in cortical gray matter volume occurs during adolescence, with greatest differences in frontal and temporal regions 3, 4

Schizophrenia is best understood as a neurodevelopmental disorder where genetic vulnerability creates a substrate that environmental factors can trigger 1, 2
Early intervention is critical, as delayed treatment may result in irreversible cognitive decline 1, 2

Families of individuals with early‑onset schizophrenia exhibit a higher prevalence of schizotypal and paranoid personality disorders among first‑degree relatives, indicating a broader familial aggregation of schizophrenia‑spectrum conditions. [5][6]

When a detailed family history reveals multiple affected members, clinicians should consider screening for rare monogenic disorders—especially those presenting with juvenile‑onset psychosis—although the majority of cases are attributable to polygenic inheritance. [5][6]

Increased predicted expression of the complement component 4A (C4A) in brain tissue is directly associated with higher schizophrenia risk; this is the most robust and replicated genetic finding for the disorder. Strong evidence from GWAS‑imputed expression analyses across multiple brain regions. 7

Genome‑wide association studies have identified hundreds of loci linked to schizophrenia, the majority being common variants with small effect sizes that reside in non‑coding regions of the genome. Evidence derives from large case‑control GWAS meta‑analyses. 8
Rare mutations (e.g., loss‑of‑function variants) contribute larger individual effects to schizophrenia risk, complementing the polygenic background of common variants. Supported by combined GWAS and sequencing data. 9

Most disease‑associated variants are non‑coding and require quantitative trait loci (QTL) analyses to determine their impact on gene expression. Functional genomics approaches have been applied to map these regulatory effects. 10

Schizophrenia risk variants are highly enriched in synaptic genes: approximately 48 % of GWAS‑identified risk loci influence expression of nearby genes, and 237 differentially expressed genes are implicated in synaptic processes during early brain development. This reflects a significant convergence on synaptic biology. 9